Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China

被引:33
|
作者
Chen, Shao-Chun [1 ,2 ]
Yuan, Liu-Feng [3 ]
Zhu, Xiao-Yu [1 ,2 ]
van der Veen, Stijn [4 ,5 ,6 ]
Yin, Yue-Ping [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Peoples R China
[2] China Ctr Dis Control & Prevent, Natl Ctr Sexually Transmitted Dis Control, Nanjing, Peoples R China
[3] Capital Med Univ, Beijing Ditan Hosp, Dept Dermatol, Beijing, Peoples R China
[4] Zhejiang Univ, Sch Med, Dept Microbiol & Parasitol, Hangzhou, Peoples R China
[5] Zhejiang Univ, Sir Run Shaw Hosp, Sch Med, Dept Dermatol, Hangzhou, Peoples R China
[6] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, Hangzhou, Peoples R China
关键词
STRAIN;
D O I
10.1093/jac/dkaa196
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Ceftriaxone resistance in Neisseria gonorrhoeae has become an imminent threat to effective control of gonorrhoea globally. In recent years, the ceftriaxone-resistant FC428 clone has shown international dissemination. After our first report of the FC428 clone in China in 2016, we now describe another six cases of FC428-related ceftriaxone-resistant N. gonorrhoeae isolates from 2017 and 2018. Objectives: To identify the phenotypic and molecular characteristics of newly reported ceftriaxone-resistant isolates in China and to investigate the relationship between these isolates and FC428 clones reported globally. Methods: Antimicrobial susceptibility to ceftriaxone, cefixime, azithromycin, spectinomycin, penicillin, ciprofloxacin and tetracycline was determined by the agar dilution method. N. gonorrhoeae multi-antigen sequence typing (NG-MAST), MLST and N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were performed for genotyping and SNPs extracted from whole-genome sequences were used for phylogenetic analysis. Results: All isolates were resistant to ceftriaxone, cefixime, penicillin, tetracycline and ciprofloxacin, but were susceptible to azithromycin and spectinomycin. NG-MAST, MLST and NG-STAR genotyping showed that all isolates shared identical or similar STs (<10 bp difference) to FC428 (NG-MAST ST3435, MLST ST1903, NG-STAR ST233) and contained the same mosaic penA allele 60.001. Phylogenetic analysis showed the Chinese isolates spreading in the whole phylogenetic tree and fully mixed with other international isolates. Half of the Chinese isolates were more closely related (<100 SNPs) to Japanese isolates than other international isolates. Conclusions: The newly reported cases in China were related to the internationally spreading FC428 clone. These isolates might have played a central role in international transmission of the FC428 clone. High ceftriaxone doses (1-2 g) still provide effective therapy.
引用
收藏
页码:2499 / 2502
页数:4
相关论文
共 50 条
  • [41] The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae
    Tickner, Jacob A.
    Lahra, Monica M.
    Whiley, David M.
    LANCET INFECTIOUS DISEASES, 2022, 22 (09): : 1271 - 1272
  • [42] Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022
    Day, Michaela
    Pitt, Rachel
    Mody, Nisha
    Saunders, John
    Rai, Rupa
    Nori, Achyuta
    Church, Hannah
    Mensforth, Sarah
    Corkin, Helen
    Jones, Jacqueline
    Naicker, Preneshni
    Khan, Wazirzada M.
    Glover, Rebecca Thomson
    Mortimer, Kalani
    Hylton, Chloe
    Moss, Elizabeth
    Pasvol, Thomas Joshua
    Richardson, Ania
    Sun, Suzy
    Woodford, Neil
    Mohammed, Hamish
    Sinka, Katy
    Fifer, Helen
    EUROSURVEILLANCE, 2022, 27 (46)
  • [43] Complete Genome Sequence of Ceftriaxone-Resistant Neisseria gonorrhoeae SS3160, Isolated in Tokyo, Japan
    Miyake, Hirofumi
    Mitobe, Morika
    Kubota, Hiroaki
    Takano, Hiroki
    Yokoyama, Keiko
    Sadamasu, Kenji
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2020, 9 (39):
  • [44] Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
    Gianecini, Ricardo
    Oviedo, Claudia
    Stafforini, Graciela
    Galarza, Patricia
    EMERGING INFECTIOUS DISEASES, 2016, 22 (06) : 1139 - 1141
  • [45] Ceftriaxone-Resistant Gonorrhea - China, 2022
    Zhu, Xiaoyu
    Xi, Yue
    Gong, Xiangdong
    Chen, Shaochun
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2024, 73 (12): : 255 - 259
  • [46] Impact of the gonococcal FC428 penA allele 60.001 on ceftriaxone resistance and biological fitness
    Zhou, Ke
    Chen, Shao-Chun
    Yang, Fan
    Van der Veen, Stijn
    Yin, Yue-Ping
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 1219 - 1229
  • [47] Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain
    Goire, N.
    Lahra, M. M.
    Ohnishi, M.
    Hogan, T.
    Liminios, A. E.
    Nissen, M. D.
    Sloots, T. P.
    Whiley, D. M.
    EUROSURVEILLANCE, 2013, 18 (14): : 18 - 23
  • [48] Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain
    Camara, Jordi
    Serra, Judit
    Ayats, Josefina
    Bastida, Teresa
    Carnicer-Pont, Dolors
    Andreu, Antonia
    Ardanuy, Carmen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) : 1858 - 1860
  • [49] High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure
    Unemo, Magnus
    Golparian, Daniel
    Nicholas, Robert
    Ohnishi, Makoto
    Gallay, Anne
    Sednaoui, Patrice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) : 1273 - 1280
  • [50] Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing
    de Curraize, Claire
    Kumanski, Sylvain
    Micaelo, Maite
    Fournet, Nelly
    La Ruche, Guy
    Meunier, Fabienne
    Amarsy, Rishma
    Jacquier, Herve
    Cambau, Emmanuelle
    Goubard, Agathe
    Bercot, Beatrice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6962 - 6964